Methods Applied to the In Vitro Primary Toxicology Testing of Natural Products: State of the Art, Strengths, and Limits

 

 Permissions and Reprints

Abstract

The present review attempts to build up a comprehensive picture of the major primary techniques used to screen and assess the cytotoxicity of plant complex mixtures. These can be based on metabolic activity, on membrane integrity, on morphological features, on cell growth; the type of cell death can also be established from more or less specific events (e.g., apoptosis, autophagy, DNA damage detection, reactive oxygen species involvement). This review will discuss the benefits, the difficulties, and the challenges that may occur along cytotoxicity testing of raw extracts and isolated natural compounds.

• References

• 1 Cragg GM, Boyd MR, Cardellina II JH, Newman DJ, Snader KM, Cloud TG. Ethnobotany and drug discovery: the experience of the US National Cancer Institute. In: Chadwick DJ, Marsh J, editors Ethnobotany and the search for new drugs. Chichester: Wiley; 1994: 178-196
  CrossrefGoogle Scholar
• 2 Evans D, Evans W, Trease G. Pharmacognosy, 16th edition. Amsterdam: Saunders Ltd.; 2009
  Google Scholar
• 3 Nguyen AT, Duez P. Cytotoxic-anticancer drugs from medicinal plants. In: Matsumoto T, editor Phytochemistry research progress. New York: Nova Science Publishers, Inc.; 2008: 193-208
  Google Scholar
• 4 Verpoorte R, Houghton PJ, Heinrich M, Mukherjee PK, Hirschmann GS, van Staden J, Yesilada E. Editorial. J Ethnopharmacol 2006; 103: 309-310
  CrossrefPubMedGoogle Scholar
• 5 Shaw D, Ladds G, Duez P, Williamson E, Chan K. Pharmacovigilance of herbal medicine. J Ethnopharmacol 2012; 140: 513-518
  CrossrefPubMedGoogle Scholar
• 6 Zhang L, Yan J, Liu X, Ye Z, Yang X, Meyboom R, Chan K, Shaw D, Duez P. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective. J Ethnopharmacol 2012; 140: 519-525
  CrossrefPubMedGoogle Scholar
• 7 Biringanine G, Vray B, Vercruysse V, Vanhaelen-Fastre R, Vanhaelen M, Duez P. Polysaccharides extracted from the leaves of Plantago palmata Hook.f. induce nitric oxide and tumor necrosis factor-alpha production by interferon-gamma-activated macrophages. Nitr Oxide 2005; 12: 1-8
  PubMedGoogle Scholar
• 8 Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 2003; 65: 1035-1041
  CrossrefPubMedGoogle Scholar
• 9 Ponzio G, Loubat A, Rochet N, Turchi L, Rezzonico R, Farahi Far D, Dulic V, Rossi B. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p 21[CIP1] induction. Oncogene 1998; 17: 1159-1166
  CrossrefPubMedGoogle Scholar
• 10 Julien C, Marcouiller F, Bretteville A, El Khoury NB, Baillargeon J, Hebert SS, Planel E. Dimethyl sulfoxide induces both direct and indirect tau hyperphosphorylation. PLoS One 2012; 7: e40020
  CrossrefPubMedGoogle Scholar
• 11 David RM, Jones HS, Panter GH, Winter MJ, Hutchinson TH, Kevin Chipman J. Interference with xenobiotic metabolic activity by the commonly used vehicle solvents dimethylsulfoxide and methanol in zebrafish (Danio rerio) larvae but not Daphnia magna . Chemosphere 2012; 88: 912-917
  CrossrefPubMedGoogle Scholar
• 12 Da Violante G, Zerrouk N, Richard I, Provot G, Chaumeil JC, Arnaud P. Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on Caco2/TC7 colon tumor cell cultures. Biol Pharm Bull 2002; 25: 1600-1603
  CrossrefPubMedGoogle Scholar
• 13 Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000; 35: 206-221
  CrossrefPubMedGoogle Scholar
• 14 Charles C, Chemais M, Stevigny C, Dubois J, Nachergael A, Duez P. Measurement of the influence of flavonoids on DNA repair kinetics using the comet assay. Food Chem 2012; 135: 2974-2981
  CrossrefPubMedGoogle Scholar
• 15 Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, Kepp O, Knight RA, Kumar S, Lipton SA, Lu X, Madeo F, Malorni W, Mehlen P, Nunez G, Peter ME, Piacentini M, Rubinsztein DC, Shi Y, Simon HU, Vandenabeele P, White E, Yuan J, Zhivotovsky B, Melino G, Kroemer G. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107-120
  CrossrefPubMedGoogle Scholar
• 16 Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nunez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009; 16: 3-11
  CrossrefPubMedGoogle Scholar
• 17 Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995; 146: 3-15
  PubMedGoogle Scholar
• 18 Schwartzman RA, Cidlowski JA. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev 1993; 14: 133-151
  CrossrefPubMedGoogle Scholar
• 19 Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med 2009; 361: 1570-1583
  CrossrefPubMedGoogle Scholar
• 20 Krysko DV, Vanden Berghe T, DʼHerde K, Vandenabeele P. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods 2008; 44: 205-221
  CrossrefPubMedGoogle Scholar
• 21 Proskuryakov SY, Konoplyannikov AG, Gabai VL. Necrosis: a specific form of programmed cell death?. Exp Cell Res 2003; 283: 1-16
  CrossrefPubMedGoogle Scholar
• 22 Zhivotovsky B. Apoptosis, necrosis and between. Cell Cycle 2004; 3: 64-66
  PubMedGoogle Scholar
• 23 Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495-516
  CrossrefPubMedGoogle Scholar
• 24 Ward TH, Cummings J, Dean E, Greystoke A, Hou JM, Backen A, Ranson M, Dive C. Biomarkers of apoptosis. Br J Cancer 2008; 99: 841-846
  CrossrefPubMedGoogle Scholar
• 25 Kiechle FL, Zhang X. Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta 2002; 326: 27-45
  CrossrefPubMedGoogle Scholar
• 26 Shen HM, Codogno P. Autophagy is a survival force via suppression of necrotic cell death. Exp Cell Res 2012; 318: 1304-1308
  CrossrefPubMedGoogle Scholar
• 27 Korsnes MS, Espenes A, Hetland DL, Hermansen LC. Paraptosis-like cell death induced by yessotoxin. Toxicol In Vitro 2011; 25: 1764-1770
  CrossrefPubMedGoogle Scholar
• 28 Sperandio S, de Belle I, Bredesen DE. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA 2000; 97: 14376-14381
  CrossrefPubMedGoogle Scholar
• 29 Sperandio S, Poksay K, de Belle I, Lafuente MJ, Liu B, Nasir J, Bredesen DE. Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ 2004; 11: 1066-1075
  CrossrefPubMedGoogle Scholar
• 30 Yoon MJ, Kim EH, Kwon TK, Park SA, Choi KS. Simultaneous mitochondrial Ca(2+) overload and proteasomal inhibition are responsible for the induction of paraptosis in malignant breast cancer cells. Cancer Lett 2012; 324: 197-209
  CrossrefPubMedGoogle Scholar
• 31 Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005; 73: 1907-1916
  CrossrefPubMedGoogle Scholar
• 32 Slater TF, Sawyer B, Straeuli U. Studies on succinate-tetrazolium reductase systems. III. Points of coupling of four different tetrazolium salts. Biochim Biophys Acta 1963; 77: 383-393
  CrossrefPubMedGoogle Scholar
• 33 Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63
  CrossrefPubMedGoogle Scholar
• 34 Berridge MV, Tan AS. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 1993; 303: 474-482
  CrossrefPubMedGoogle Scholar
• 35 Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 2005; 11: 127-152
  PubMedGoogle Scholar
• 36 Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988; 48: 4827-4833
  PubMedGoogle Scholar
• 37 Goodwin CJ, Holt SJ, Downes S, Marshall NJ. Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS. J Immunol Methods 1995; 179: 95-103
  CrossrefPubMedGoogle Scholar
• 38 Shoemaker M, Cohen I, Campbell M. Reduction of MTT by aqueous herbal extracts in the absence of cells. J Ethnopharmacol 2004; 93: 381-384
  CrossrefPubMedGoogle Scholar
• 39 Bruggisser R, von Daeniken K, Jundt G, Schaffner W, Tullberg-Reinert H. Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta Med 2002; 68: 445-448
  Article in Thieme ConnectPubMedGoogle Scholar
• 40 Wisman KN, Perkins AA, Jeffers MD, Hagerman AE. Accurate assessment of the bioactivities of redox-active polyphenolics in cell culture. J Agric Food Chem 2008; 56: 7831-7837
  CrossrefPubMedGoogle Scholar
• 41 Wang P, Henning SM, Heber D. Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS One 2010; 5: e10202
  CrossrefPubMedGoogle Scholar
• 42 Muraina IA, Suleiman MM, Eloff JN. Can MTT be used to quantify the antioxidant activity of plant extracts?. Phytomedicine 2009; 16: 665-668
  CrossrefPubMedGoogle Scholar
• 43 Pagliacci MC, Spinozzi F, Migliorati G, Fumi G, Smacchia M, Grignani F, Riccardi C, Nicoletti I. Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. Eur J Cancer 1993; 29?A: 1573-1577
  PubMedGoogle Scholar
• 44 Naoi T, Shibuya N, Inoue H, Mita S, Kobayashi S, Watanabe K, Orino K. The effect of tert-butylhydroquinone-induced oxidative stress in MDBK cells using XTT assay: implication of tert-butylhydroquinone-induced NADPH generating enzymes. J Vet Med Sci 2010; 72: 321-326
  CrossrefPubMedGoogle Scholar
• 45 Hamid R, Rotshteyn Y, Rabadi L, Parikh R, Bullock P. Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro 2004; 18: 703-710
  CrossrefPubMedGoogle Scholar
• 46 Thorne N, Auld DS, Inglese J. Apparent activity in high-throughput screening: origins of compound-dependent assay interference. Curr Opin Chem Biol 2010; 14: 315-324
  CrossrefPubMedGoogle Scholar
• 47 Yu HG, Chung H, Yu YS, Seo JM, Heo JW. A new rapid and non-radioactive assay for monitoring and determining the proliferation of retinal pigment epithelial cells. Korean J Ophthalmol 2003; 17: 29-34
  CrossrefPubMedGoogle Scholar
• 48 Zhi-Jun Y, Sriranganathan N, Vaught T, Arastu SK, Ansar Ahmed S. A dye-based lymphocyte proliferation assay that permits multiple immunological analyses: mRNA, cytogenetic, apoptosis, and immunophenotyping studies. J Immunol Methods 1997; 210: 25-39
  CrossrefPubMedGoogle Scholar
• 49 Erikstein BS, Hagland HR, Nikolaisen J, Kulawiec M, Singh KK, Gjertsen BT, Tronstad KJ. Cellular stress induced by resazurin leads to autophagy and cell death via production of reactive oxygen species and mitochondrial impairment. J Cell Biochem 2010; 111: 574-584
  CrossrefPubMedGoogle Scholar
• 50 Goegan P, Johnson G, Vincent R. Effects of serum protein and colloid on the alamarBlue assay in cell cultures. Toxicol In Vitro 1995; 9: 257-266
  CrossrefPubMedGoogle Scholar
• 51 Repetto G, del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 2008; 3: 1125-1131
  CrossrefPubMedGoogle Scholar
• 52 Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985; 24: 119-124
  CrossrefPubMedGoogle Scholar
• 53 Hall JO, Novakofski JE, Beasley VR. Neutral red assay modification to prevent cytotoxicity and improve reproducibility using E-63 rat skeletal muscle cells. Biotechnol Histochem 1998; 73: 211-221
  CrossrefPubMedGoogle Scholar
• 54 Higashi T, Isomoto A, Tyuma I, Kakishita E, Uomoto M, Nagai K. Quantitative and continuous analysis of ATP release from blood platelets with firefly luciferase luminescence. Thromb Haemost 1985; 53: 65-69
  PubMedGoogle Scholar
• 55 Crouch SP, Kozlowski R, Slater KJ, Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 1993; 160: 81-88
  CrossrefPubMedGoogle Scholar
• 56 Squatrito RC, Connor JP, Buller RE. Comparison of a novel redox dye cell growth assay to the ATP bioluminescence assay. Gynecol Oncol 1995; 58: 101-105
  CrossrefPubMedGoogle Scholar
• 57 Fan F, Wood KV. Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol 2007; 5: 127-136
  CrossrefPubMedGoogle Scholar
• 58 Ulukaya E, Ozdikicioglu F, Oral AY, Demirci M. The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested. Toxicol In Vitro 2008; 22: 232-239
  CrossrefPubMedGoogle Scholar
• 59 Thorne N, Inglese J, Auld DS. Illuminating insights into firefly luciferase and other bioluminescent reporters used in chemical biology. Chem Biol 2010; 17: 646-657
  CrossrefPubMedGoogle Scholar
• 60 Bakhtiarova A, Taslimi P, Elliman SJ, Kosinski PA, Hubbard B, Kavana M, Kemp DM. Resveratrol inhibits firefly luciferase. Biochem Biophys Res Commun 2006; 351: 481-484
  CrossrefPubMedGoogle Scholar
• 61 Leitao JM, Esteves da Silva JC. Firefly luciferase inhibition. J Photochem Photobiol B 2010; 101: 1-8
  CrossrefPubMedGoogle Scholar
• 62 Shimomura Y, Kawada T, Suzuki M. Capsaicin and its analogs inhibit the activity of NADH-coenzyme Q oxidoreductase of the mitochondrial respiratory chain. Arch Biochem Biophys 1989; 270: 573-577
  CrossrefPubMedGoogle Scholar
• 63 Cheng SC, Pardini RS. Structure-inhibition relationships of various phenolic compounds towards mitochondrial respiration. Pharmacol Res Commun 1978; 10: 897-910
  CrossrefPubMedGoogle Scholar
• 64 Gledhill JR, Montgomery MG, Leslie AGW, Walker JE. Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols. Proc Natl Acad Sci USA 2007; 104: 13632-13637
  CrossrefPubMedGoogle Scholar
• 65 Chan GK, Kleinheinz TL, Peterson D, Moffat JG. A simple high-content cell cycle assay reveals frequent discrepancies between cell number and ATP and MTS proliferation assays. PLoS One 2013; 8: e63583
  CrossrefPubMedGoogle Scholar
• 66 Kitami T, Logan DJ, Negri J, Hasaka T, Tolliday NJ, Carpenter AE, Spiegelman BM, Mootha VK. A chemical screen probing the relationship between mitochondrial content and cell size. PLoS One 2012; 7: e33755
  CrossrefPubMedGoogle Scholar
• 67 Kluza J, Marchetti P, Gallego MA, Lancel S, Fournier C, Loyens A, Beauvillain JC, Bailly C. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene 2004; 23: 7018-7030
  CrossrefPubMedGoogle Scholar
• 68 Renner K, Amberger A, Konwalinka G, Kofler R, Gnaiger E. Changes of mitochondrial respiration, mitochondrial content and cell size after induction of apoptosis in leukemia cells. Biochim Biophys Acta 2003; 1642: 115-123
  CrossrefPubMedGoogle Scholar
• 69 Abe K, Matsuki N. Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT. Neurosci Res 2000; 38: 325-329
  CrossrefPubMedGoogle Scholar
• 70 Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983; 64: 313-320
  CrossrefPubMedGoogle Scholar
• 71 Weyermann J, Lochmann D, Zimmer A. A practical note on the use of cytotoxicity assays. Int J Pharm 2005; 288: 369-376
  CrossrefPubMedGoogle Scholar
• 72 Schofield P, Mbugua DM, Pell AN. Analysis of condensed tannins: a review. Anim Feed Sci Technol 2001; 91: 21-40
  CrossrefPubMedGoogle Scholar
• 73 Bruneton J. Pharmacognosie : Phytochimie, Plantes médicinales, 4th edition. Paris: Lavoisier; 2009
  Google Scholar
• 74 Goldstein JL, Swain T. The inhibition of enzymes by tannins. Phytochemistry 1965; 4: 185-192
  CrossrefPubMedGoogle Scholar
• 75 Kendig DM, Tarloff JB. Inactivation of lactate dehydrogenase by several chemicals: implications for in vitro toxicology studies. Toxicol In Vitro 2007; 21: 125-132
  CrossrefPubMedGoogle Scholar
• 76 Bottger S, Hofmann K, Melzig MF. Saponins can perturb biologic membranes and reduce the surface tension of aqueous solutions: a correlation?. Bioorg Med Chem 2012; 20: 2822-2828
  CrossrefPubMedGoogle Scholar
• 77 Grankvist K, Lernmark A, Taljedal IB. Alloxan cytotoxicity in vitro. Microscope photometric analyses of Trypan Blue uptake by pancreatic islet cells in suspension. Biochem J 1977; 162: 19-24
  PubMedGoogle Scholar
• 78 Uliasz TF, Hewett SJ. A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture. J Neurosci Methods 2000; 100: 157-163
  CrossrefPubMedGoogle Scholar
• 79 Hu J, el-Fakahany EE. An artifact associated with using trypan blue exclusion to measure effects of amyloid beta on neuron viability. Life Sci 1994; 55: 1009-1016
  CrossrefPubMedGoogle Scholar
• 80 Johnson I, Spence M. The Molecular Probes® Handbook, 11th edition, Section 12.5. Available at http://www.lifetechnologies.com/be/en/home/references/molecular-probes-the-handbook.html Accessed December 11, 2013.
  PubMedGoogle Scholar
• 81 Sonnenbichler J, Scalera F, Sonnenbichler I, Weyhenmeyer R. Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells. J Pharmacol Exp Ther 1999; 290: 1375-1383
  PubMedGoogle Scholar
• 82 Nunez R. DNA measurement and cell cycle analysis by flow cytometry. Curr Issues Mol Biol 2001; 3: 67-70
  PubMedGoogle Scholar
• 83 Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139: 271-279
  CrossrefPubMedGoogle Scholar
• 84 Taupin P. BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation. Brain Res Rev 2007; 53: 198-214
  CrossrefPubMedGoogle Scholar
• 85 Munshi A, Hobbs M, Meyn R. Clonogenic cell survival assay. In: Blumenthal RD, editor Methods in molecular medicine. Totawa: Humana Press; 2005: 21-28
  Google Scholar
• 86 Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro . Nat Protoc 2006; 1: 2315-2319
  CrossrefPubMedGoogle Scholar
• 87 Quto b SS, Ng CE. Comparison of apoptotic, necrotic and clonogenic cell death and inhibition of cell growth following camptothecin and X-radiation treatment in a human melanoma and a human fibroblast cell line. Cancer Chemother Pharmacol 2002; 49: 167-175
  CrossrefPubMedGoogle Scholar
• 88 Saraste A. Morphologic criteria and detection of apoptosis. Herz 1999; 24: 189-195
  CrossrefPubMedGoogle Scholar
• 89 Wang C, Jiang Z, Yao J, Wu X, Sun L, Liu C, Duan W, Yan M, Liu J, Zhang L. Participation of cathepsin B in emodin-induced apoptosis in HK-2 cells. Toxicol Lett 2008; 181: 196-204
  CrossrefPubMedGoogle Scholar
• 90 Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, Cohen GM, De Laurenzi V, De Maria R, Deshmukh M, Dynlacht BD, El-Deiry WS, Flavell RA, Fulda S, Garrido C, Golstein P, Gougeon ML, Green DR, Gronemeyer H, Hajnoczky G, Hardwick JM, Hengartner MO, Ichijo H, Jaattela M, Kepp O, Kimchi A, Klionsky DJ, Knight RA, Kornbluth S, Kumar S, Levine B, Lipton SA, Lugli E, Madeo F, Malomi W, Marine JC, Martin SJ, Medema JP, Mehlen P, Melino G, Moll UM, Morselli E, Nagata S, Nicholson DW, Nicotera P, Nunez G, Oren M, Penninger J, Pervaiz S, Peter ME, Piacentini M, Prehn JH, Puthalakath H, Rabinovich GA, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Scorrano L, Simon HU, Steller H, Tschopp J, Tsujimoto Y, Vandenabeele P, Vitale I, Vousden KH, Youle RJ, Yuan J, Zhivotovsky B, Kroemer G. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 2009; 16: 1093-1107
  CrossrefPubMedGoogle Scholar
• 91 Bury M, Novo-Uzal E, Andolfi A, Cimini S, Wauthoz N, Heffeter P, Lallemand B, Avolio F, Delporte C, Cimmino A, Dubois J, Van Antwerpen P, Zonno MC, Vurro M, Poumay Y, Berger W, Evidente A, De Gara L, Kiss R, Locato V. Ophiobolin A, a sesterterpenoid fungal phytotoxin, displays higher in vitro growth-inhibitory effects in mammalian than in plant cells and displays in vivo antitumor activity. Int J Oncol 2013; 43: 575-585
  PubMedGoogle Scholar
• 92 Nacoulma A. Reprogrammation métabolique induite dans les tissus hyperplasique formés chez le tabac infecté par Rodococcusfascians: aspects fondamentaux et applications potentielles [PhD Thesis]. Brussels: Université Libre de Bruxelles; 2013
  PubMedGoogle Scholar
• 93 Debeir O, Megalizzi V, Warzee N, Kiss R, Decaestecker C. Videomicroscopic extraction of specific information on cell proliferation and migration in vitro . Exp Cell Res 2008; 314: 2985-2998
  CrossrefPubMedGoogle Scholar
• 94 Hu Q, Noor M, Wong YF, Hylands PJ, Simmonds MS, Xu Q, Jiang D, Hendry BM. In vitro anti-fibrotic activities of herbal compounds and herbs. Nephrol Dial Transplant 2009; 24: 3033-3041
  CrossrefPubMedGoogle Scholar
• 95 Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39-51
  CrossrefPubMedGoogle Scholar
• 96 Verzola D, Gandolfo MT, Salvatore F, Villaggio B, Gianiorio F, Traverso P, Deferrari G, Garibotto G. Testosterone promotes apoptotic damage in human renal tubular cells. Kidney Int 2004; 65: 1252-1261
  CrossrefPubMedGoogle Scholar
• 97 Jacob MC, Favre M, Bensa JC. Membrane cell permeabilization with saponin and multiparametric analysis by flow cytometry. Cytometry 1991; 12: 550-558
  CrossrefPubMedGoogle Scholar
• 98 Wang C, Wu X, Chen M, Duan W, Sun L, Yan M, Zhang L. Emodin induces apoptosis through caspase 3-dependent pathway in HK-2 cells. Toxicology 2007; 231: 120-128
  CrossrefPubMedGoogle Scholar
• 99 Fan C, Wang W, Zhao B, Zhang S, Miao J. Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells. Bioorg Med Chem 2006; 14: 3218-3222
  CrossrefPubMedGoogle Scholar
• 100 Li B. Chaine respiratoire et pore de transition de permeabilité mitochondriale dans la cardioprotection [PhD Thesis]. Lyon: Université Claude Bernard; 2009
  PubMedGoogle Scholar
• 101 Zhu B, Zhai Q, Yu B. Tanshinone IIA protects rat primary hepatocytes against carbon tetrachloride toxicity via inhibiting mitochondria permeability transition. Pharm Biol 2010; 48: 484-487
  CrossrefPubMedGoogle Scholar
• 102 Baumann S, Fas SC, Giaisi M, Muller WW, Merling A, Gulow K, Edler L, Krammer PH, Li-Weber M. Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosis. Blood 2008; 111: 2354-2363
  CrossrefPubMedGoogle Scholar
• 103 Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988; 175: 184-191
  CrossrefPubMedGoogle Scholar
• 104 Fairbairn DW, Olive PL, OʼNeill KL. The comet assay: a comprehensive review. Mutat Res 1995; 339: 37-59
  CrossrefPubMedGoogle Scholar
• 105 Anderson D, Yu TW, McGregor DB. Comet assay responses as indicators of carcinogen exposure. Mutagenesis 1998; 13: 539-555
  CrossrefPubMedGoogle Scholar
• 106 Rojas E, Lopez MC, Valverde M. Single cell gel electrophoresis assay: methodology and applications. J Chromatogr B Biomed Sci Appl 1999; 722: 225-254
  CrossrefPubMedGoogle Scholar
• 107 Hartmann A, Speit G. The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay). Toxicol Lett 1997; 90: 183-188
  CrossrefPubMedGoogle Scholar
• 108 Horvathova E, Dusinska M, Shaposhnikov S, Collins AR. DNA damage and repair measured in different genomic regions using the comet assay with fluorescent in situ hybridization. Mutagenesis 2004; 19: 269-276
  CrossrefPubMedGoogle Scholar
• 109 Gedik CM, Ewen SW, Collins AR. Single-cell gel electrophoresis applied to the analysis of UV-C damage and its repair in human cells. Int J Radiat Biol 1992; 62: 313-320
  CrossrefPubMedGoogle Scholar
• 110 Olive PL. DNA damage and repair in individual cells: applications of the comet assay in radiobiology. Int J Radiat Biol 1999; 75: 395-405
  CrossrefPubMedGoogle Scholar
• 111 Bocker W, Bauch T, Muller WU, Streffer C. Image analysis of comet assay measurements. Int J Radiat Biol 1997; 72: 449-460
  CrossrefPubMedGoogle Scholar
• 112 Olive PL, Banath JP, Durand RE. Heterogeneity in radiation induced DNA damage and repair in tumor and normal cells measured using the ʼcometʼ assay. Radiat Res 1990; 122: 86-94
  CrossrefPubMedGoogle Scholar
• 113 Speit G, Vasquez M, Hartmann A. The comet assay as an indicator test for germ cell genotoxicity. Mutat Res 2009; 681: 3-12
  CrossrefPubMedGoogle Scholar
• 114 Berthelot-Ricou A, Perrin J, Di Giorgio C, De Meo M, Botta A, Courbiere B. Comet assay on mouse oocytes: an improved technique to evaluate genotoxic risk on female germ cells. Fertil Steril 2011; 95: 1452-1457
  CrossrefPubMedGoogle Scholar
• 115 Duez P, Dehon G, Kumps A, Dubois J. Statistics of the Comet assay: a key to discriminate between genotoxic effects. Mutagenesis 2003; 18: 159-166
  CrossrefPubMedGoogle Scholar
• 116 Speit G, Brendler-Schwaab S, Hartmann A, Pfuhler S. The in vivo comet assay: use and status in genotoxicity testing. Mutagenesis 2005; 20: 245-254
  CrossrefPubMedGoogle Scholar
• 117 Kim YJ, Park HJ, Yoon SH, Kim MJ, Leem KH, Chung JH, Kim HK. Anticancer effects of oligomeric proanthocyanidins on human colorectal cancer cell line, SNU-C4. World J Gastroenterol 2005; 11: 4674-4678
  PubMedGoogle Scholar
• 118 Martins C, Doran C, Laires A, Rueff J, Rodrigues AS. Genotoxic and apoptotic activities of the food flavourings myristicin and eugenol in AA8 and XRCC1 deficient EM9 cells. Food Chem Toxicol 2011; 49: 385-392
  CrossrefPubMedGoogle Scholar
• 119 Heatwole VM. TUNEL assay for apoptotic cells. Methods Mol Biol 1999; 115: 141-148
  PubMedGoogle Scholar
• 120 Stahelin BJ, Marti U, Solioz M, Zimmermann H, Reichen J. False positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate. Mol Pathol 1998; 51: 204-208
  CrossrefPubMedGoogle Scholar
• 121 Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y. GammaH2AX and cancer. Nat Rev Cancer 2008; 8: 957-967
  CrossrefPubMedGoogle Scholar
• 122 Muslimovic A, Ismail IH, Gao Y, Hammarsten O. An optimized method for measurement of gamma-H2AX in blood mononuclear and cultured cells. Nat Protoc 2008; 3: 1187-1193
  CrossrefPubMedGoogle Scholar
• 123 Smart DJ, Ahmedi KP, Harvey JS, Lynch AM. Genotoxicity screening via the gammaH2AX by flow assay. Mutat Res 2011; 715: 25-31
  CrossrefPubMedGoogle Scholar
• 124 Verschaeve L, Juutilainen J, Lagroye I, Miyakoshi J, Saunders R, de Seze R, Tenforde T, van Rongen E, Veyret B, Xu Z. In vitro and in vivo genotoxicity of radiofrequency fields. Mutat Res 2010; 705: 252-268
  CrossrefPubMedGoogle Scholar
• 125 Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res 2002; 158: 486-492
  CrossrefPubMedGoogle Scholar
• 126 Bouquet F, Muller C, Salles B. The loss of gamma H2AX signal is a marker of DNA double strand breaks repair only a low levels of DNA damage. Cell Cycle 2006; 5: 1116-1122
  CrossrefPubMedGoogle Scholar
• 127 Maron DM, Ames BN. Revised methods for the Salmonella mutagenicity test. Mutat Res 1983; 113: 173-215
  Google Scholar
• 128 Ramos A, Edreira A, Vizoso A, Betancourt J, Lopez M, Decalo M. Genotoxicity of an extract of Calendula officinalis L. J Ethnopharmacol 1998; 61: 49-55
  CrossrefPubMedGoogle Scholar
• 129 Zhang H, Cifone MA, Murli H, Erexson GL, Mecchi MS, Lawlor TE. Application of simplified in vitro screening tests to detect genotoxicity of aristolochic acid. Food Chem Toxicol 2004; 42: 2021-2028
  CrossrefPubMedGoogle Scholar
• 130 Ogura R, Ikeda N, Yuki K, Morita O, Saigo K, Blackstock C, Nishiyama N, Kasamatsu T. Genotoxicity studies on green tea catechin. Food Chem Toxicol 2008; 46: 2190-2200
  CrossrefPubMedGoogle Scholar
• 131 EMEA. Overview of comments received on draft ʼguideline on the assessment of genotoxic constituents in herbal Substances/preparationsʼ (emea/hmpc/107079/2007). Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2009/09/WC500003570.pdf Accessed August 2013.
  PubMedGoogle Scholar
• 132 Bolognesi C. Genotoxicity of pesticides: a review of human biomonitoring studies. Mutat Res 2003; 543: 251-272
  CrossrefPubMedGoogle Scholar
• 133 Fenech M. The in vitro micronucleus technique. Mutat Res 2000; 455: 81-95
  CrossrefPubMedGoogle Scholar
• 134 Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate jr. M, Kirchner S, Lorge E, Morita T, Norppa H, Surralles J, Vanhauwaert A, Wakata A. Report from the in vitro micronucleus assay working group. Mutat Res 2003; 540: 153-163
  CrossrefPubMedGoogle Scholar
• 135 OECD. OECD guideline for the testing of chemicals: mammalian erythrocyte micronucleus test. Chemical safety and biosafety 1997; Testing of chemicals. Available at http://www.oecd.org/chemicalsafety/testing/oecdguidelinesforthetestingofchemicals.htm Accessed December 11, 2013.
  PubMedGoogle Scholar
• 136 Westerink WM, Schirris TJ, Horbach GJ, Schoonen WG. Development and validation of a high-content screening in vitro micronucleus assay in CHO-k1 and HepG2 cells. Mutat Res 2011; 724: 7-21
  CrossrefPubMedGoogle Scholar
• 137 Lambert IB, Singer TM, Boucher SE, Douglas GR. Detailed review of transgenic rodent mutation assays. Mutat Res 2005; 590: 1-280
  PubMedGoogle Scholar
• 138 Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils – a review. Food Chem Toxicol 2008; 46: 446-475
  CrossrefPubMedGoogle Scholar
• 139 Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95
  CrossrefPubMedGoogle Scholar
• 140 Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ. Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys 1989; 14: 175-185
  CrossrefPubMedGoogle Scholar
• 141 Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver diseases: past, present, future. Phytother Res 2010; 24: 1423-1432
  CrossrefPubMedGoogle Scholar
• 142 Paya M, Halliwell B, Hoult JR. Interactions of a series of coumarins with reactive oxygen species. Scavenging of superoxide, hypochlorous acid and hydroxyl radicals. Biochem Pharmacol 1992; 44: 205-214
  CrossrefPubMedGoogle Scholar
• 143 Carr A, Frei B. Does vitamin C act as a pro-oxidant under physiological conditions?. FASEB J 1999; 13: 1007-1024
  PubMedGoogle Scholar
• 144 Lapidot T, Walker MD, Kanner J. Can apple antioxidants inhibit tumor cell proliferation? Generation of H(2)O(2) during interaction of phenolic compounds with cell culture media. J Agric Food Chem 2002; 50: 3156-3160
  CrossrefPubMedGoogle Scholar
• 145 OʼBrien PJ. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact 1991; 80: 1-41
  CrossrefPubMedGoogle Scholar
• 146 Brisson M, Nguyen T, Wipf P, Joo B, Day BW, Skoko JS, Schreiber EM, Foster C, Bansal P, Lazo JS. Redox regulation of Cdc25B by cell-active quinolinediones. Mol Pharmacol 2005; 68: 1810-1820
  PubMedGoogle Scholar
• 147 Vasquez DR, Verrax J, Valderrama JA, Calderon PB. Aminopyrimidoisoquinolinequinone (APIQ) redox cycling is potentiated by ascorbate and induces oxidative stress leading to necrotic-like cancer cell death. Invest New Drugs 2012; 30: 1003-1011
  CrossrefPubMedGoogle Scholar
• 148 Gomes A, Fernandes E, Lima JL. Fluorescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods 2005; 65: 45-80
  CrossrefPubMedGoogle Scholar
• 149 Eruslanov E, Kusmartsev S. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol Biol 2010; 594: 57-72
  PubMedGoogle Scholar
• 150 Wardman P. Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects. Free Radic Biol Med 2007; 43: 995-1022
  CrossrefPubMedGoogle Scholar
• 151 Saengkhae C, Loetchutinat C, Garnier-Suillerot A. Kinetic analysis of fluorescein and dihydrofluorescein effluxes in tumour cells expressing the multidrug resistance protein, MRP1. Biochem Pharmacol 2003; 65: 969-977
  CrossrefPubMedGoogle Scholar
• 152 Hempel SL, Buettner GR, OʼMalley YQ, Wessels DA, Flaherty DM. Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2′,7′-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic Biol Med 1999; 27: 146-159
  CrossrefPubMedGoogle Scholar
• 153 Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 2003; 66: 1499-1503
  CrossrefPubMedGoogle Scholar
• 154 Baker MA, Cerniglia GJ, Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 1990; 190: 360-365
  CrossrefPubMedGoogle Scholar
• 155 Gallwitz H, Bonse S, Martinez-Cruz A, Schlichting I, Schumacher K, Krauth-Siegel RL. Ajoene is an inhibitor and subversive substrate of human glutathione reductase and Trypanosoma cruzi trypanothione reductase: crystallographic, kinetic, and spectroscopic studies. J Med Chem 1999; 42: 364-372
  CrossrefPubMedGoogle Scholar
• 156 Rice GC, Bump EA, Shrieve DC, Lee W, Kovacs M. Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo . Cancer Res 1986; 46: 6105-6110
  PubMedGoogle Scholar
• 157 Kim DP, Yahav J, Sperandeo M, Maloney L, McTigue M, Lin F, Clark RA. High cell density attenuates reactive oxygen species: implications for in vitro assays. Wound Repair Regen 2012; 20: 74-82
  CrossrefPubMedGoogle Scholar
• 158 Patton S, Kurtz GW. 2-Thiobarbituric acid as a reagent for detecting milk fat oxidation. J Dairy Sci 1951; 34: 669-674
  CrossrefPubMedGoogle Scholar
• 159 Guillen-Sans R, Guzman-Chozas M. The thiobarbituric acid (TBA) reaction in foods: a review. Crit Rev Food Sci Nutr 1998; 38: 315-330
  CrossrefPubMedGoogle Scholar
• 160 Lefevre G, Beljean-Leymarie M, Beyerle F, Bonnefont-Rousselot D, Cristol JP, Therond P, Torreilles J. [Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances]. Ann Biol Clin (Paris) 1998; 56: 305-319
  PubMedGoogle Scholar
• 161 Louzao MC, Ares IR, Cagide E, Espina B, Vilarino N, Alfonso A, Vieytes MR, Botana LM. Palytoxins and cytoskeleton: An overview. Toxicon 2011; 57: 460-469
  CrossrefPubMedGoogle Scholar
• 162 Peterson JR, Mitchison TJ. Small molecules, big impact: a history of chemical inhibitors and the cytoskeleton. Chem Biol 2002; 9: 1275-1285
  CrossrefPubMedGoogle Scholar
• 163 Borisy GG, Taylor EW. The mechanism of action of colchicine. Binding of colchincine-3H to cellular protein. J Cell Biol 1967; 34: 525-533
  CrossrefPubMedGoogle Scholar
• 164 Nicolaou KC, Finlay MR, Ninkovic S, King NP, He Y, Li T, Sarabia F, Vourloumis D. Synthesis and biological properties of C12, 13-cyclopropyl-epothilone A and related epothilones. Chem Biol 1998; 5: 365-372
  CrossrefPubMedGoogle Scholar
• 165 Small J, Rottner K, Hahne P, Anderson KI. Visualising the actin cytoskeleton. Microsc Res Tech 1999; 47: 3-17
  CrossrefPubMedGoogle Scholar
• 166 Hayot C, Debeir O, Van Ham P, Van Damme M, Kiss R, Decaestecker C. Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicol Appl Pharmacol 2006; 211: 30-40
  CrossrefPubMedGoogle Scholar
• 167 Simmons SO, Fan CY, Ramabhadran R. Cellular stress response pathway system as a sentinel ensemble in toxicological screening. Toxicol Sci 2009; 111: 202-225
  CrossrefPubMedGoogle Scholar
• 168 Tsien RY. The green fluorescent protein. Annu Rev Biochem 1998; 67: 509-544
  CrossrefPubMedGoogle Scholar
• 169 Crawford AD, Esguerra CV, de Witte PA. Fishing for drugs from nature: zebrafish as a technology platform for natural product discovery. Planta Med 2008; 74: 624-632
  Article in Thieme ConnectPubMedGoogle Scholar
• 170 Borner FU, Schutz H, Wiedemann P. The fragility of omics risk and benefit perceptions. Toxicol Lett 2011; 201: 249-257
  CrossrefPubMedGoogle Scholar
• 171 Bishop WE, Clarke DP, Travis CC. The genomic revolution: what does it mean for risk assessment?. Risk Anal 2001; 21: 983-987
  CrossrefPubMedGoogle Scholar
• 172 Heijne WH, Kienhuis AS, van Ommen B, Stierum RH, Groten JP. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology. Expert Rev Proteomics 2005; 2: 767-780
  CrossrefPubMedGoogle Scholar
• 173 Aardema MJ, MacGregor JT. Toxicology and genetic toxicology in the new era of “toxicogenomics”: impact of “-omics” technologies. Mutat Res 2002; 499: 13-25
  CrossrefPubMedGoogle Scholar
• 174 Marchant GE. Toxicogenomics and toxic torts. Trends Biotechnol 2002; 20: 329-332
  CrossrefPubMedGoogle Scholar
• 175 Marques A, Lourenço HM, Nunes ML, Roseiro C, Santos C, Barranco A, Rainieri S, Langerholc T, Cencic A. New tools to assess toxicity, bioaccessibility and uptake of chemical contaminants in meat and seafood. Food Res Int 2011; 44: 510-522
  CrossrefPubMedGoogle Scholar
• 176 Lay jr. JO, Borgmann S, Liyanage R, Wilkins CL. Problems with the “omics”. Trends Anal Chem 2006; 25: 1046-1056
  CrossrefPubMedGoogle Scholar
• 177 Searfoss GH, Ryan TP, Jolly RA. The role of transcriptome analysis in pre-clinical toxicology. Curr Mol Med 2005; 5: 53-64
  CrossrefPubMedGoogle Scholar
• 178 Ouedraogo M, Baudoux T, Stevigny C, Nortier J, Colet JM, Efferth T, Qu F, Zhou J, Chan K, Shaw D, Pelkonen O, Duez P. Review of current and “omics” methods for assessing the toxicity (genotoxicity, teratogenicity and nephrotoxicity) of herbal medicines and mushrooms. J Ethnopharmacol 2012; 140: 492-512
  CrossrefPubMedGoogle Scholar
• 179 Selderslaghs IW, Blust R, Witters HE. Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds. Reprod Toxicol 2012; 33: 142-154
  CrossrefPubMedGoogle Scholar
• 180 Blechinger SR, Warren jr. JT, Kuwada JY, Krone PH. Developmental toxicology of cadmium in living embryos of a stable transgenic zebrafish line. Environ Health Perspect 2002; 110: 1041-1046
  PubMedGoogle Scholar
• 181 Van Raamsdonk JM, Hekimi S. Reactive oxygen species and aging in Caenorhabditis elegans: causal or casual relationship?. Antioxid Redox Signal 2010; 13: 1911-1953
  CrossrefPubMedGoogle Scholar
• 182 Brenner S. The genetics of Caenorhabditis elegans . Genetics 1974; 77: 71-94
  PubMedGoogle Scholar
• 183 Leung MC, Williams PL, Benedetto A, Au C, Helmcke KJ, Aschner M, Meyer JN. Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci 2008; 106: 5-28
  CrossrefPubMedGoogle Scholar
• 184 Gnoula C, Guissou I, Dubois J, Duez P. 5(6)-Carboxyfluorescein diacetate as an indicator of Caenorhabditis elegans viability for the development of an in vitro anthelmintic drug assay. Talanta 2007; 71: 1886-1892
  CrossrefPubMedGoogle Scholar
• 185 Valerio jr. LG. In silico toxicology for the pharmaceutical sciences. Toxicol Appl Pharmacol 2009; 241: 356-370
  CrossrefPubMedGoogle Scholar